By the same authors

From the same journal

Regenerative medicine and responsible research and innovation: proposals for a responsible acceleration to the clinic

Research output: Contribution to journalArticle

Standard

Regenerative medicine and responsible research and innovation : proposals for a responsible acceleration to the clinic. / Webster, Andrew Joseph.

In: REGENERATIVE MEDICINE, Vol. 12, No. 7, 02.11.2017, p. 853-864.

Research output: Contribution to journalArticle

Harvard

Webster, AJ 2017, 'Regenerative medicine and responsible research and innovation: proposals for a responsible acceleration to the clinic', REGENERATIVE MEDICINE, vol. 12, no. 7, pp. 853-864. https://doi.org/10.2217/rme-2017-0028

APA

Webster, A. J. (2017). Regenerative medicine and responsible research and innovation: proposals for a responsible acceleration to the clinic. REGENERATIVE MEDICINE, 12(7), 853-864. https://doi.org/10.2217/rme-2017-0028

Vancouver

Webster AJ. Regenerative medicine and responsible research and innovation: proposals for a responsible acceleration to the clinic. REGENERATIVE MEDICINE. 2017 Nov 2;12(7):853-864. https://doi.org/10.2217/rme-2017-0028

Author

Webster, Andrew Joseph. / Regenerative medicine and responsible research and innovation : proposals for a responsible acceleration to the clinic. In: REGENERATIVE MEDICINE. 2017 ; Vol. 12, No. 7. pp. 853-864.

Bibtex - Download

@article{e93d9f3f65a94182adcd19d21803412f,
title = "Regenerative medicine and responsible research and innovation: proposals for a responsible acceleration to the clinic",
abstract = "This paper asks how regenerative medicine can be examined through the {\textquoteleft}responsible research and innovation{\textquoteright} (RRI) approach which has been developed over the past decade. It describes the drivers to the development of RRI, and then argues for the need to understand innovation itself through drawing on social science analysis rooted in science and technology studies. The paper then identifies a number of highly specific challenges faced by the regenerative medicine field and the implications these have for value creation. It offers a number of examples of how a combined RRI/science and technology studies perspective can identify priority areas for policy and concludes by arguing for a {\textquoteleft}responsible acceleration{\textquoteright}, more likely to foster readiness at a time when much of the policy domain is pushing for ever-rapid access to cell therapies.",
author = "Webster, {Andrew Joseph}",
note = "{\textcopyright} 2017 Future Science Group. This is an author-produced version of the published paper. Uploaded in accordance with the publisher{\textquoteright}s self-archiving policy. Further copying may not be permitted; contact the publisher for details. ",
year = "2017",
month = nov,
day = "2",
doi = "10.2217/rme-2017-0028",
language = "English",
volume = "12",
pages = "853--864",
journal = "REGENERATIVE MEDICINE",
issn = "1746-0751",
publisher = "Future Medicine Ltd.",
number = "7",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Regenerative medicine and responsible research and innovation

T2 - proposals for a responsible acceleration to the clinic

AU - Webster, Andrew Joseph

N1 - © 2017 Future Science Group. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details.

PY - 2017/11/2

Y1 - 2017/11/2

N2 - This paper asks how regenerative medicine can be examined through the ‘responsible research and innovation’ (RRI) approach which has been developed over the past decade. It describes the drivers to the development of RRI, and then argues for the need to understand innovation itself through drawing on social science analysis rooted in science and technology studies. The paper then identifies a number of highly specific challenges faced by the regenerative medicine field and the implications these have for value creation. It offers a number of examples of how a combined RRI/science and technology studies perspective can identify priority areas for policy and concludes by arguing for a ‘responsible acceleration’, more likely to foster readiness at a time when much of the policy domain is pushing for ever-rapid access to cell therapies.

AB - This paper asks how regenerative medicine can be examined through the ‘responsible research and innovation’ (RRI) approach which has been developed over the past decade. It describes the drivers to the development of RRI, and then argues for the need to understand innovation itself through drawing on social science analysis rooted in science and technology studies. The paper then identifies a number of highly specific challenges faced by the regenerative medicine field and the implications these have for value creation. It offers a number of examples of how a combined RRI/science and technology studies perspective can identify priority areas for policy and concludes by arguing for a ‘responsible acceleration’, more likely to foster readiness at a time when much of the policy domain is pushing for ever-rapid access to cell therapies.

U2 - 10.2217/rme-2017-0028

DO - 10.2217/rme-2017-0028

M3 - Article

VL - 12

SP - 853

EP - 864

JO - REGENERATIVE MEDICINE

JF - REGENERATIVE MEDICINE

SN - 1746-0751

IS - 7

ER -